Timothy P Clackson Theseus Pharmaceuticals, Inc. (THRX) insider trading activity

THRX Quotes by TradingView

Timothy P Clackson is President and CEO of Theseus Pharmaceuticals, Inc.. Currently has a direct ownership of 351,030 shares of THRX, which is worth approximately $0. The most recent transaction as insider was on Nov 11, 2022, when has been sold 2,500 shares (Common Stock) at a price of $6.8 per share, resulting in proceeds of $17,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 351K
0% 3M change
0% 12M change
Total Value Held $0

TIMOTHY P CLACKSON Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 11 2022
BUY
Open market or private purchase
$17,000 $6.8 p/Share
2,500 Added 0.71%
351,030 Common Stock
Dec 21 2021
BUY
Open market or private purchase
$25,376 $9.76 p/Share
2,600 Added 0.74%
348,530 Common Stock

Also insider at

FMTX
Forma Therapeutics Holdings, Inc. Healthcare
Director
FSTX
F-star Therapeutics, Inc. Healthcare
Director
ELEV
Elevation Oncology, Inc. Healthcare
TPC

Timothy P Clackson

President and CEO
Hopkinton, MA

Track Institutional and Insider Activities on THRX

Follow Theseus Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells THRX shares.

Notify only if

Insider Trading

Get notified when an Theseus Pharmaceuticals, Inc. insider buys or sells THRX shares.

Notify only if

News

Receive news related to Theseus Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on THRX